This article is
- freely available
Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo
Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China
College of Pharmacy, Jinan University, Guangzhou 510632, China
These authors contributed equally to this work.
* Authors to whom correspondence should be addressed.
Received: 18 October 2012; in revised form: 20 November 2012 / Accepted: 29 November 2012 / Published: 11 December 2012
Abstract: Arca subcrenata Lischke is a marine traditional Chinese medicine. The study investigated the antitumor effects of P2, a polypeptide fraction from A. subcrenata, and its toxicity in vitro and in vivo. The results showed that P2 could inhibit the proliferation of seven tumor cell lines, especially in HeLa and HT-29 cell lines. The IC50 values were 11.43 μg/mL for HeLa and 13.00 μg/mL for HT-29 treated by P2 for 48 h. P2 had little cytotoxicity on normal liver cells (L-02). The maximum tolerated dose (MTD) of P2 on KM mice was 1000 mg/kg by i.p. or i.v. The tumor growth inhibitory ratios of P2 were 26.4%, 41.4% and 46.4% for H-22, and 34.0%, 45.8% and 60.1% for S-180 tumor-bearing mice. The results demonstrated that P2 might be a potential antitumor agent with high efficiency in dose-dependent and time-dependent manners and low toxicity.
Keywords: Arca subcrenata; polypeptide; antitumor; S-180; H-22
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Hu, X.; Song, L.; Huang, L.; Zheng, Q.; Yu, R. Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo. Mar. Drugs 2012, 10, 2782-2794.
Hu X, Song L, Huang L, Zheng Q, Yu R. Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo. Marine Drugs. 2012; 10(12):2782-2794.
Hu, Xianjing; Song, Liyan; Huang, Lijiao; Zheng, Qin; Yu, Rongmin. 2012. "Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo." Mar. Drugs 10, no. 12: 2782-2794.